Anemia associated with advanced prostatic adenocarcinoma: Effects of recombinant human erythropoietin

Prostate

Volumn 31, Issue 3, 1997, Pages 153-160

  Beshara, Soheir ^a   Letocha, Henry ^a   Linde, Torbjörn ^a   Wikström, Björn ^a   Sandhagen, Bo ^a   Nilsson, Sten ^a   Danielson, Bo G ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

anemia; erythropoietin; hemorheology; prostatic adenocarcinoma; transferrin receptor

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN RECEPTOR;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFICACY; ERYTHROPOIESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IRON STORAGE; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; SUBCUTANEOUS DRUG ADMINISTRATION;

ADENOCARCINOMA; AGED; ANEMIA; BLOOD TRANSFUSION; BLOOD VISCOSITY; BONE MARROW; ERYTHROPOIETIN; HEMOGLOBINS; HUMANS; IRON; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RECEPTORS, TRANSFERRIN; RECOMBINANT PROTEINS; TRANSFERRIN;

EID: 0030922642     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970515)31:3<153::AID-PROS2>3.0.CO;2-M     Document Type: Article

References (31)

1. Henry DH: Recombinant human erythropoietin in the treatment of anemia associated with solid tumors. In Bauer C, Koch KM, Scigalla P Wieczorek L (eds): "Erythropoietin: Molecular Physiology and Clinical Applications." New York: Marcel Dekker, 1993, pp 293-298.
2. Miller CB, Jones RJ, Piantadosi S, Abeloff MD, Spivak JL: Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 322:1689-1692, 1990.
3. Cash JM, Scars DA: The anemia of chronic disease: Spectrum of associated disease in a series of unselected hospitalized patients. Am J Med 87:638-644, 1989.
4. Shilling RF: Anemia of chronic disease: A misnomer. 2. Ann Intern Med 115:572-573, 1991.
5. Jelkman W, Wolff M, Frandrey J: Modulation of the production of erythropoietin by cytokines: In vitro studies and their clinical implications. Contrib Nephrol 87:68-77, 1990.
6. Cazzola M, Ponchio L, Beguin Y, Rosti V, Bergamaschi G, Liberato NL, Fregoni V, Nalli G, Barosi G, Ascari E: Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood 79: 29-37, 1992.
7. Platanias LC, Miller CB, Mick R, Hart RD, Ozer H, McEvilly J-M, Jones RJ, Ratain MJ: Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients. J Clin Oncol 9:2021-2026, 1991.
8. Ludwig H, Fritz E, Kortzmann H, Höcker P, Gisslinger H, Barnas U: Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 322:1639-1699, 1990.
9. Oster W, Herrmann F, Gamm H, Zeile G, Lindemann A, Müller G, Brune T, Kraemer H-P, Mertelsmann R: Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration. J Clin Oncol 8:956-962, 1990.
10. Ponchio L, Beguin Y, Farina G, Pedrazzoli P, Pedrotti C, Poggi G, Rosti V, Bergamschi G, Battistel V, Cazzola M: Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia. Haematologica 77:494-501, 1992.
11. Berliner N, Duffy TP: Approach to the patient with anemia. In Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ (eds): "Hematology. Basic Principles and Practice." New York: Churchill Livingstone, 1991, pp 302-311.
12. Egrie JC, Lane J, Gaines Das RE, Tam RC: Development of radioimmunoassay for human erythropoietin using recombinant erythropoietin as tracer and immunogen. J Immunol Methods 99:235-241, 1987.
13. Cazzola M, Beguin Y: New tools for clinical evaluation of erythron function in man. Br J Haematol 80:278-284, 1992.
14. Bergrem H, Danielson BJ, Eckardt K-U, Kurtz A, Stridsberg M: A case of antierythropoietin antibodies following recombinant human erythropoietin treatment. In Bauer C, Koch KM, Scigalla P, Wieczorek L (eds): "Erythropoietin: Molecular Physiology and Clinical Applications." New York: Marcel Dekker, 1993, pp 256-273.
15. Beguin Y: Contribution of the soluble transferrin receptor to the quantitative evaluation of erythroid marrow function. Erythropoiesis 4:99-109, 1993.
16. Huebers HA, Beguin Y, Pootrakul P, Einspahr D, Finch CA: Intact transferrin receptor in human plasma and their relation to erythropoiesis. Blood 75:102-107, 1990.
17. International Committee for Standardization in Haematology: Guidelines for measurement of blood viscosity and erythrocyte deformability. Clin Hemorheol 6:439-453, 1986.
18. Sandhagen B: Analysis of haemorheological variables -Methodology and reference values. Upsala J Med Sci 94:81-87, 1989.
19. Stäubli M, Stone PCW, Straub PW, Stuart J: Evaluation of methods for measuring erythrocyte deformability. Clin Hemorheol 6:589-602, 1986.
20. Cartwright GE: The anemia of chronic disorders. Semin Hematol 3:351-357, 1966.
21. Spivak JL: Recombinant human erythropoietin and the anemia of cancer. Blood 84:997-1004, 1994.
22. Singh A, Eckardt K-U, Zimmermann A, Götz K-H, Hamann M, Ratcliff OJ, Kurtz A, Reinhart WH: Increased plasma viscosity as a reason for inappropriate erythropoietin formation. J Clin Invest 91:251-256, 1993.
23. Krantz SB: Erythropoietin and the anaemia of chronic disease. Nephrol Dial Transplant 10:10-17, 1995.
24. Flowers CH, Skikne BS, Covell AM, Cook JD: The clinical measurement of serum transferrin receptor. J Lab Clin Med 114:368-377, 1989.
25. Raaf HN, Jacobsen DW, Savon S, Green R: Serum transferrin receptor level is not altered in invasive adenocarcinoma of the breast. Am J Clin Pathol 99:232-237, 1993.
26. Doll DC, Weiss RB: Neoplasia and the erythron. J Clin Oncol 3:429-446, 1985.
27. Duffy TP: Hematologic aspects of systemic disease. In Handin R, Lux SE, Stossel TP (eds): "Blood. Principles and Practice of Hematology." Philadelphia: JB Lippincott, 1995, pp 1925-1944.
28. Henry DH, Ables RI: Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: Results of double-blind and open-label follow-up studies. Semin Oncol 21(suppl 3):21-28, 1994.
29. Ludwig H, Fritz E, Leitgeb C, Percherstorfer M, Samonigg H, Schuster J: Prediction of response to erythropoietin treatment in chronic anemia of cancer. Blood 84:1056-1063, 1994.
30. Erslev AJ: Erythropoietin. N Engl J Med 324:1339-1344, 1991.
31. Ganser A: Clinical use of erythropoietin in hematology and oncology. In "Overview of the Literature Related to Erythropoietin. 1993." Vol. 5. Amsterdam Excerpta Medica 1994, pp 45-51.